ea0026p234 | Pituitary | ECE2011
van Bunderen C C
, van Nieuwpoort I C
, Arwert L I
, Heymans M W
, Franken A A M
, Koppeschaar H P F
, van der Lely A J
, Drent M L
Introduction: Adults with GH deficiency (GHD) have a decreased life expectancy due to cardiovascular diseases (CVD). Recombinant GH treatment has made replacement therapy an option in adults with GHD. Data on long-term efficacy and safety are limited and the implication for life expectancy remains to be established.Methods: The Dutch National Registry of GH Treatment in Adults was founded to gain more insight into long-term efficacy and safety of GH ther...